Vietnam Artemisinic Acid Market Report and Forecast 2026-2034

Study Period

2021-2034

Market (2025)

USD 2.10 Billion

Market (2034)

USD 3.48 Billion

CAGR

3.48 billion

Major Markets Players

Bayer Vietnam Ltd., DHG Pharmaceutical Joint Stock Company, Cipla Limited, Novartis Vietnam Company Limited, Domesco Medical Import Export Joint Stock Corporation (DOMESCO) and Others

*Note: Partial List Randomly Ordered

Vietnam Artemisinic Acid Market Statistics and Insights

Vietnam Artemisinic Acid Market Insights & Analysis

The Vietnam Artemisinic Acid Market is anticipated to register a 5.78% CAGR during 2026-2034. The market size was valued at USD 2.10 billion in 2025 and is projected to reach USD 3.48 billion by 2034. The market is witnessing steady growth driven by increasing demand for antimalarial drugs in Southeast Asia and other malaria-endemic regions.

 Artemisinic acid serves as a key precursor in the production of artemisinin-based combination therapies (ACTs), which are widely recommended by global health organizations. Government initiatives aimed at malaria elimination and international funding from organizations such as the Global Fund are supporting market expansion. Additionally, advancements in pharmaceutical manufacturing and increasing investments in drug production are enhancing supply capabilities. Vietnam’s strong pharmaceutical sector and export potential are further contributing to the growth of the artemisinic acid market.

Vietnam Artemisinic Acid Market Dynamics

Key Market Driver: Rising Demand for Antimalarial Drugs and Disease Control Programs

The increasing prevalence of malaria in certain regions and ongoing eradication programs are major drivers for the Vietnam artemisinic acid market. Artemisinin-based combination therapies are the standard treatment for malaria, driving consistent demand for artemisinic acid. Government-led initiatives and global health programs are focusing on improving access to effective antimalarial treatments. Studies indicate that millions of malaria cases are reported annually worldwide, emphasizing the need for reliable drug supply. Vietnam’s role as a manufacturing hub for pharmaceutical ingredients is further supporting market growth. The continuous demand for life-saving medications is a key factor driving this market.

Major Industry Challenge: Supply Chain Dependency and Raw Material Variability

The production of artemisinic acid is highly dependent on raw materials derived from Artemisia annua plants, leading to variability in supply and pricing. Fluctuations in agricultural output due to climate conditions can impact raw material availability. Additionally, reliance on specific supply chains can create vulnerabilities in production. Ensuring consistent quality and yield of raw materials is a challenge for manufacturers. These factors can affect production stability and pricing, posing challenges for market growth. Developing alternative synthesis methods and improving supply chain resilience are essential to address these issues.

Emerging Trend Shaping Outlook: Advancement in Synthetic Biology and Semi Synthetic Production Methods

Advancements in synthetic biology and semi-synthetic production methods are transforming the artemisinic acid market. Biotechnology-based approaches are enabling the production of artemisinic acid through engineered microorganisms, reducing dependency on plant-based sources. Semi-synthetic methods are gaining popularity due to their scalability and cost efficiency. Research and development efforts are focused on improving production yields and reducing costs. Additionally, collaborations between pharmaceutical companies and research institutions are driving innovation. This trend is expected to enhance supply stability and support long-term market growth.

Vietnam Artemisinic Acid Market Segment-wise Analysis

By Application

• Antimalarial Injection
• Antimalarial Tablets

The antimalarial tablets segment dominates the Vietnam Artemisinic Acid Market, accounting for approximately 63% of total revenue share. This dominance is driven by the widespread use of oral medications in malaria treatment due to ease of administration and cost-effectiveness. Tablets are preferred in large-scale treatment programs and public health initiatives. Antimalarial injections are used in severe cases and emergency settings, contributing to a smaller but critical segment. Increasing government focus on malaria control and the availability of affordable oral medications are supporting growth in the tablets segment.

By Type

• Total Synthesis
• Semi synthesis

The semi synthesis segment leads the market with an estimated 59% share, driven by its cost efficiency and scalability compared to total synthesis methods. Semi-synthetic production combines plant-derived and synthetic processes, ensuring a stable supply of artemisinic acid. Total synthesis, although technologically advanced, is less widely adopted due to higher production costs and complexity. However, ongoing research in synthetic biology is expected to improve the feasibility of total synthesis methods. The shift toward efficient and sustainable production processes is supporting growth across both segments.

Regional Projection of Vietnam Artemisinic Acid Market

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

Southern Vietnam leads the market, accounting for approximately 46% share due to the presence of major pharmaceutical manufacturing hubs and export-oriented facilities. The region benefits from strong industrial infrastructure and access to international markets. Northern Vietnam also contributes significantly, supported by growing pharmaceutical investments and research activities. Central Vietnam is gradually emerging as a growth region with increasing focus on healthcare development and industrial expansion.

Vietnam Artemisinic Acid Market: Recent Develpoment (2025)

• DHG Pharmaceutical Joint Stock Company expanded production capacity to support increasing demand for antimalarial drug ingredients
• Novartis Vietnam Company Limited strengthened supply chain operations ensuring consistent availability of artemisinin based therapies
• Cipla Limited enhanced collaboration with local manufacturers to improve distribution of antimalarial drugs across Vietnam
• Sanofi Aventis Vietnam invested in research initiatives focusing on improving production efficiency of artemisinic acid

Vietnam Artemisinic Acid Market Future Outlook (2034)

The Vietnam Artemisinic Acid Market is expected to grow at a CAGR of 5.78%, reaching USD 3.48 billion by 2034. Growth will be driven by increasing demand for antimalarial drugs, advancements in synthetic biology, and expansion of pharmaceutical manufacturing capabilities. Technological innovations in semi-synthetic production will enhance efficiency and reduce dependency on raw materials. Government initiatives and global health programs will continue to support market demand. Additionally, increasing export opportunities and investments in research and development will drive long-term market expansion.

Why Choose This Report?

• Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
• Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk & capitalizing on growth.
• Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development & marketing effectiveness.
• Delivers competitive analysis & benchmarking, uncovering the strengths & weaknesses of market competitors to guide strategies.
• Consolidate comprehensive market intelligence, reducing reasoning & streamlining research efforts.
• Facilitates customized market segmentation & risk mitigation strategies, fine-tuned to the business objectives.
• Aids in identifying both market challenges & untapped opportunities within the industry to drive long-term business growth.
• Provides valuable information based on actual customer data & search trends.